HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephan A Mayer Selected Research

Biomarkers (Surrogate Marker)

8/2023Neutrophil-Lymphocyte ratio is associated with poor clinical outcome after mechanical thrombectomy in stroke in patients with COVID-19.
1/2021Association of Serum IL-6 (Interleukin 6) With Functional Outcome After Intracerebral Hemorrhage.
1/2020Fully Automated Segmentation Algorithm for Perihematomal Edema Volumetry After Spontaneous Intracerebral Hemorrhage.
1/2020The Curing Coma Campaign: Framing Initial Scientific Challenges-Proceedings of the First Curing Coma Campaign Scientific Advisory Council Meeting.
1/2018Cerebral Pulsatility Index Is Elevated in Patients with Elevated Right Atrial Pressure.
5/2014Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephan A Mayer Research Topics

Disease

76Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
03/2024 - 01/2002
41Cerebral Hemorrhage
05/2024 - 10/2002
33Stroke (Strokes)
05/2024 - 03/2005
30Hemorrhage
12/2023 - 01/2002
21Hematoma
03/2024 - 10/2002
20Brain Ischemia (Cerebral Ischemia)
12/2022 - 03/2005
19Ischemic Stroke
05/2024 - 01/2004
16Brain Injuries (Brain Injury)
10/2022 - 11/2002
14Coma (Comas)
01/2024 - 11/2002
14Hypertension (High Blood Pressure)
02/2018 - 01/2005
12Cerebral Infarction
12/2020 - 02/2005
12Aneurysm (Aneurysms)
10/2019 - 09/2003
11Hemorrhagic Stroke
02/2024 - 02/2007
11Critical Illness (Critically Ill)
12/2021 - 12/2004
11Infarction (Infarctions)
12/2020 - 08/2005
10Fever (Fevers)
07/2017 - 03/2003
9Edema (Dropsy)
03/2024 - 05/2002
9Seizures (Absence Seizure)
01/2019 - 02/2002
8Inflammation (Inflammations)
12/2021 - 03/2005
8Ischemia
05/2020 - 09/2006
8Status Epilepticus (Complex Partial Status Epilepticus)
08/2015 - 02/2002
7Heart Arrest (Cardiac Arrest)
07/2023 - 09/2006
7Hypotension (Low Blood Pressure)
01/2020 - 03/2006
7Pneumonia (Pneumonitis)
10/2015 - 01/2006
6Hyperglycemia
05/2024 - 01/2006
6Intracranial Aneurysm (Cerebral Aneurysm)
12/2022 - 09/2003
6Intracranial Hemorrhages (Intracranial Hemorrhage)
09/2022 - 01/2007
6Infections
09/2020 - 01/2008
6Intracranial Vasospasm
05/2020 - 09/2002
6Intracranial Hypertension
01/2018 - 08/2005
6Anemia
02/2015 - 03/2006
5Hypothermia
07/2014 - 11/2005
5Brain Edema (Cerebral Edema)
06/2011 - 08/2005
4Consciousness Disorders
01/2024 - 03/2003
4COVID-19
08/2023 - 09/2020
4Clinical Deterioration
12/2022 - 08/2006
4Traumatic Brain Injuries (Traumatic Brain Injury)
01/2011 - 01/2004
4Vascular System Injuries
07/2010 - 01/2003
4Spasm (Spasms)
06/2009 - 04/2003
4Hemophilia A (Haemophilia)
02/2007 - 10/2002
3Respiratory Insufficiency (Respiratory Failure)
12/2023 - 06/2002
3Rupture
12/2021 - 01/2010
3Venous Thromboembolism
12/2021 - 01/2020
3Heart Failure
12/2021 - 01/2006
3Pulmonary Edema
01/2019 - 03/2006
3Hydrocephalus (Hydrocephaly)
01/2019 - 09/2007
3Hyponatremia
01/2018 - 03/2006
3Out-of-Hospital Cardiac Arrest
05/2017 - 01/2009
3Cognitive Dysfunction
02/2016 - 06/2009
2Thrombocytopenia (Thrombopenia)
08/2023 - 01/2009
2Neoplasms (Cancer)
01/2023 - 09/2022

Drug/Important Bio-Agent (IBA)

19Factor VIIa (Activated Factor VII)IBA
02/2024 - 10/2002
18Hemostatics (Antihemorrhagics)IBA
03/2024 - 10/2002
18recombinant FVIIa (rFVIIa)FDA Link
12/2023 - 10/2002
14Glucose (Dextrose)FDA LinkGeneric
05/2024 - 03/2007
10Factor VII (Proconvertin)IBA
09/2023 - 01/2005
9clazosentanIBA
12/2022 - 07/2011
8Nimodipine (Modus)FDA LinkGeneric
12/2020 - 01/2004
7Tissue Plasminogen Activator (Alteplase)FDA Link
01/2023 - 01/2004
6Biomarkers (Surrogate Marker)IBA
08/2023 - 05/2014
6Hemoglobins (Hemoglobin)IBA
01/2021 - 04/2003
5Insulin (Novolin)FDA Link
05/2024 - 04/2006
5Oxygen (Dioxygen)IBA
04/2014 - 03/2009
4AnticoagulantsIBA
03/2024 - 01/2007
4EG-1962IBA
12/2020 - 01/2017
4Anticonvulsants (Antiepileptic Drugs)IBA
01/2019 - 02/2002
4Antihypertensive Agents (Antihypertensives)IBA
02/2018 - 12/2010
4Pyruvic Acid (Pyruvate)IBA
06/2011 - 06/2010
4Lactic Acid (Lactate)FDA LinkGeneric
06/2011 - 06/2010
3Heparin (Liquaemin)FDA LinkGeneric
08/2023 - 01/2009
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2023 - 01/2002
3Therapeutic UsesIBA
01/2022 - 10/2020
3C-Reactive ProteinIBA
12/2021 - 09/2011
3BenzodiazepinesIBA
12/2019 - 02/2002
3Endothelin Receptor AntagonistsIBA
10/2019 - 06/2012
3MagnesiumIBA
03/2019 - 01/2004
3Troponin IIBA
01/2019 - 01/2005
3Nicardipine (Dagan)FDA LinkGeneric
01/2018 - 02/2013
3CreatinineIBA
06/2014 - 03/2007
36-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
11/2011 - 01/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2010 - 04/2004
2Indicators and Reagents (Reagents)IBA
08/2023 - 07/2023

Therapy/Procedure

72Therapeutics
05/2024 - 02/2002
19Thrombectomy
12/2023 - 07/2017
17Critical Care (Surgical Intensive Care)
01/2022 - 05/2002
15Length of Stay
09/2022 - 02/2002
8Artificial Respiration (Mechanical Ventilation)
04/2023 - 08/2005
8Induced Hypothermia
10/2022 - 09/2006
5Thrombolytic Therapy
12/2021 - 04/2004
5Catheters
01/2020 - 01/2005
4Ventriculostomy
01/2020 - 03/2004
4Activities of Daily Living (ADL)
02/2016 - 07/2004
4Aftercare (After-Treatment)
06/2012 - 02/2002
4Craniotomy
08/2011 - 08/2005
4Resuscitation
06/2011 - 04/2006
4Glycemic Control
10/2010 - 11/2005
3Tracheostomy
12/2023 - 08/2015
3Ventriculoperitoneal Shunt
01/2018 - 09/2007
3Rewarming
05/2017 - 07/2009
2Anticoagulation Reversal
03/2024 - 12/2023